Ignite Creation Date:
2025-12-18 @ 8:15 AM
Ignite Modification Date:
2025-12-18 @ 8:15 AM
Study NCT ID:
NCT06324123
Status:
None
Last Update Posted:
2024-12-31 00:00:00
First Post:
2024-03-06 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Observational Study Aimed at Evaluating the Trend of Neuropathic Pain
Sponsor:
None
Organization:
Study Overview
Official Title:
Observational Study Aimed at Evaluating the Trend of Neuropathic Pain Through the Reduction of the NRS Questionnaire Score in Patients Treated With PEACETIL
Status:
None
Status Verified Date:
2024-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NEURATIL
Brief Summary:
The present study aims to evaluate the trend of neuropathic pain in patients treated with Peacetil for a period of two months.
Neuropathic pain will me assessed through the Numeric Rating Scale (NRS) questionnaire score.
Neuropathic pain will me assessed through the Numeric Rating Scale (NRS) questionnaire score.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: